These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2783485)
21. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. Martin DR; Yuryev A; Kalli KR; Fearon DT; Ahearn JM J Exp Med; 1991 Dec; 174(6):1299-311. PubMed ID: 1660522 [TBL] [Abstract][Full Text] [Related]
22. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2). Micklem KJ; Sim RB; Sim E Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618 [TBL] [Abstract][Full Text] [Related]
23. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. Rayhel EJ; Dehoff MH; Holers VM J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386 [TBL] [Abstract][Full Text] [Related]
24. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry. Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415 [TBL] [Abstract][Full Text] [Related]
25. Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia. Kai C; Okada N; Okada H Jpn J Cancer Res; 1988 Jul; 79(7):805-8. PubMed ID: 2971638 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies. Barel M; Fiandino A; Lyamani F; Frade R Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614 [TBL] [Abstract][Full Text] [Related]
28. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. Molina H; Kinoshita T; Inoue K; Carel JC; Holers VM J Immunol; 1990 Nov; 145(9):2974-83. PubMed ID: 2145366 [TBL] [Abstract][Full Text] [Related]
29. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells. Cantaloube JF; Piechaczyk M; Calender A; Lenoir G; Minty A; Carrière D; Fischer E; Poncelet P Eur J Immunol; 1990 Feb; 20(2):409-16. PubMed ID: 1690137 [TBL] [Abstract][Full Text] [Related]
30. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276 [TBL] [Abstract][Full Text] [Related]
31. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586 [TBL] [Abstract][Full Text] [Related]
32. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789 [TBL] [Abstract][Full Text] [Related]
33. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345 [TBL] [Abstract][Full Text] [Related]
34. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products. Martin BK; Weis JH Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486 [TBL] [Abstract][Full Text] [Related]
35. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions. Mold C; Cooper NR; Nemerow GR J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615 [TBL] [Abstract][Full Text] [Related]
36. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion. Petzer AL; Schulz TF; Stauder R; Eigentler A; Myones BL; Dierich MP Immunology; 1988 Jan; 63(1):47-53. PubMed ID: 2448232 [TBL] [Abstract][Full Text] [Related]
37. Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge. Tan SS; O'Toole EM; Kurtz CB; Weis JH Immunology; 1993 May; 79(1):82-8. PubMed ID: 8509145 [TBL] [Abstract][Full Text] [Related]
38. Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. Holguin MH; Kurtz CB; Parker CJ; Weis JJ; Weis JH J Immunol; 1990 Sep; 145(6):1776-81. PubMed ID: 2144008 [TBL] [Abstract][Full Text] [Related]
39. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. Christensen SM; Martin BK; Tan SS; Weis JH J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways. Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]